(2,3-Difluoro-4-methylphenyl)boronic acid, 95.0%, 250mg

1-(2-Chloro-5-methoxyphenyl)ethan-1-one, 97%, 1g

4-(Bromomethyl)-1-methoxy-2-nitrobenzene, 95.0%, 100mg

2-Amino-6-trifluoromethylbenzoic acid, 98.0%, 10g

4-Bromo-1-naphthaldehyde, 95.0%, 100g

4-Oxazolecarboxamide, 2-(2-chloro-6-fluorophenyl)-5-[[4-(4-morpholinylcarbonyl)phenyl]amino]-, 25mg

2-Chloro-6-fluoro-3-formylphenylboronic acid, 98+%, 1g

8-Bromo-quinoline, 97.00%, 500g

9-METHYLFLUORENE, 95.0%, 1g

3,4-dichloro-2-methoxybenzenesulfonyl chloride, 95.0%, 1g

LOMITAPIDE, 95%, 250mg

(3aR,4R,5R,6aS)-2-Oxo-4-((R,E)-3-oxo-4-(m-tolyl)pent-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-5-yl benzoate, 98%, 50mg

Tris(3-hydroxypropyltriazolylmethyl)amine, min 95%, 100 mg, emballage plastique.